Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.


Scandinavian Biopharma has been awarded 7.4 million EUR from the EU for clinical trials of ETVAX® – a unique and newly developed vaccine against diarrheal disease

2019-01-23

In international competition Scandinavian Biopharma has been awarded a grant of 7,4 million Euro for clinical trials of the ETEC vaccine ETVAX®.  The clinical trials will be conducted in the African countries Zambia and The Gambia. The newly developed vaccine ETVAX® targets diarrhea caused by ETEC – an enteric bacteria responsible for hundred thousands of […]

Scandinavian Biopharma Wishes Happy Holidays by donating food to an orphanage in Grand Popo, Benin!

2018-12-21

With this year’s Christmas gift we wish to improve the situation for orphan children in the village of Grand Popo in Benin. For us, working with vaccine development both to protect travellers and children under five years in low and middle-income countries, it comes natural to support an orphanage in Grand Popo. In the spirit […]

Tomas Åslund joins Scandinavian Biopharma as VP Manufacturing

2018-12-20

Scandinavian Biopharma continues to expand and strengthen its organization. Tomas Åslund has now started as VP Manufacturing at Scandinavian Biopharma. Tomas has more than 30 years’ experience from the pharmaceutical and life science industry within the field of recombinant protein drugs. Most recently Tomas worked at Octapharma as Project Manager and Responsible Scientist, leading process […]